![Fred Grossman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fred Grossman
Präsident bei COYA THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Fred Grossman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
COYA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.07.2023 | - |
Präsident | 17.07.2023 | - | |
Reunion Neuroscience, Inc.
![]() Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 03.04.2023 | - |
Karriereverlauf von Fred Grossman
Ehemalige bekannte Positionen von Fred Grossman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Empyrean Neuroscience, Inc.
![]() Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Empyrean Neuroscience is an American genetic engineering company that specializes in developing neuroactive therapeutics to treat neuropsychiatric and neurologic disorders. The company is based in and, but their location is not specified. The company's platform allows for the creation of small molecule therapeutics through precision genetic modification, transformation, and regeneration of fungi and plants. Additionally, their platform enables the discovery of novel small molecules that may exhibit therapeutic properties. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | 01.01.2023 |
MESOBLAST LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 19.08.2019 | 02.02.2022 |
GLENMARK PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | 01.01.2019 |
Präsident | 01.01.2018 | 01.01.2019 | |
Glenmark Pharmaceuticals Inc., USA
![]() Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2015 | 01.08.2018 |
Präsident | 01.11.2015 | 01.08.2018 | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01.10.2010 | 01.10.2015 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.07.2004 | 01.10.2010 |
Mesoblast, Inc.
![]() Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 11.08.2019 | - |
Ausbildung von Fred Grossman
Hahnemann University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Indien | 2 |
Australien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 6 |
President | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
MESOBLAST LIMITED | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
![]() | Health Technology |
COYA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Glenmark Pharmaceuticals Inc., USA
![]() Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Health Technology |
Mesoblast, Inc.
![]() Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
Empyrean Neuroscience, Inc.
![]() Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Empyrean Neuroscience is an American genetic engineering company that specializes in developing neuroactive therapeutics to treat neuropsychiatric and neurologic disorders. The company is based in and, but their location is not specified. The company's platform allows for the creation of small molecule therapeutics through precision genetic modification, transformation, and regeneration of fungi and plants. Additionally, their platform enables the discovery of novel small molecules that may exhibit therapeutic properties. | Health Technology |
- Börse
- Insiders
- Fred Grossman
- Erfahrung